GlaxoSmithKline Pharmaceuticals Limited
Nippon India Mutual Fund's holding in GlaxoSmithKline Pharmaceuticals was newly disclosed at 1.05%, with the fund holding 17,76,623 shares.
A leading pharmaceutical company, GlaxoSmithKline Pharmaceuticals researches, manufactures, and distributes a broad range of medicines and vaccines across India and internationally. The company operates across multiple therapeutic areas including respiratory, oncology, dermatology, and vaccines, serving healthcare providers and patients. Its integrated operations span drug development, manufacturing, quality assurance, and distribution networks throughout the country and beyond.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.